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Pharmaceuticals and personal care products (PPCPs) are a unique group of emerging environmental
contaminants, due to their inherent ability to induce physiological effects in human at low doses. An
increasing number of studies has conﬁrmed the presence of various PPCPs in different environmental
compartments, which raises concerns about the potential adverse effects to humans and wildlife.
Therefore, this article reviews the current state-of-knowledge on PPCPs in the freshwater aquatic
environment. The environmental risk posed by these contaminants is evaluated in light of the persis-
tence, bioaccumulation and toxicity criteria. Available literature on the sources, transport and degra-
dation of PPCPs in the aquatic environment are evaluated, followed by a comprehensive review of the
reported concentrations of different PPCP groups in the freshwater aquatic environment (water, sedi-
ment and biota) of the ﬁve continents. Finally, future perspectives for research on PPCPs in the fresh-
water aquatic environment are discussed in light of the identiﬁed research gaps in current knowledge.
Copyright © 2017, KeAi Communications Co., Ltd. Production and hosting by Elsevier B.V. on behalf of
KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pharmaceuticals are deﬁned as prescription, over the counter
and veterinary therapeutic drugs used to prevent or treat human
and animal diseases, while personal care products (PCPs) are used
mainly to improve the quality of daily life [16]. Over the past few
years, there has been increasing awareness of the unintentional
presence of PPCPs in various compartments of the aquatic envi-
ronment (e.g. water, sediments and biota) at concentrations
capable of causing detrimental effects to the aquatic organisms.
This has become a major concern because PPCPs are extensively
and increasingly used in human and veterinary medicine, resulting
in their continuous release to the environment [119]. Priority
pollutant lists have been developed both by the European Union
(EU) and the United States Environmental Protection Agency
(USEPA) identifying a wide variety of chemicals present in waste-
waters and storm water runoff that may pose a threat to receiving
water bodies including surfacewater. In the year 2000, an initial list, and Environmental Sciences,
ted Kingdom.
-Elwafa Abdallah).
nications Co., Ltd.
o., Ltd. Production and hosting by E
ons.org/licenses/by-nc-nd/4.0/).of 33 priority substances was also identiﬁed under the EU Water
Framework Directive (WFD) 2000/60/EC to be used as a control
measure for the next 20 years. In 2007, PPCPs such as diclofenac,
iopamidol, musks and carbamazepine were identiﬁed as future
emerging priority candidates. Ibuprofen, cloﬁbric acid, triclosan,
phthalates and bisphenol A are proposed additions to this list [45].
Due to their large number and diverse chemical nature of PPCPs,
the Environment Agency (EA) of England and Wales proposed a
ranking system for these chemicals according to their perceived
relative risk, with the aim of identifying substances with great
potential to pose a risk to the aquatic environment. This ranking
system used a combination of traditional risk assessment proced-
ures, persistence, bioaccumulation and toxicity (PBT) criteria,
occurrence data from various countries, availability of suitable
analytical methods, and aimed to include compounds representa-
tive of different therapeutic classes. Based on this procedure, the
top 10 compounds were: Lofepramine, Dextropropoxyphene, Pro-
cyclidine, Tramadol, Paracetamol, Clotrimazole, Thioridazine,
Mebeverine, Aminophylline, and Tamoxifen [6]. In a similar exer-
cise, using the OSPAR selection and prioritisation mechanism for
hazardous substances (DYNAMEC), an alternative list of priority
substances was identiﬁed, including: Lofepramine, Dextro-
propoxyphene, Procyclidine, Tramadol, Paracetamol, Clotrimazole,lsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article
A.J. Ebele et al. / Emerging Contaminants 3 (2017) 1e162Thioridazine, Mebeverine, Aminophylline, Tamoxifen, Fluoxetine,
Trimethoprim, Sulfamethoxazole, Fenoﬁbrate1, and Diclofenac
(OSPAR Commission, 2002 [188]).
Since then, several studies have investigated concentrations of
these priority and related PPCPs in the fresh water aquatic envi-
ronment. This paper aims to: (a) provide an overview of the envi-
ronmental risk associated with PPCPs; (b) discuss the
environmental fate and behaviour of PPCPs in the aquatic system;
(c) review the current state-of-knowledge on the levels and trends
of PPCPs in various compartments of the fresh water environment;
and (d) discuss the current research gaps and provide recommen-
dations for future research.
1.1. Environmental risk of PPCPs
The detection of chemical compounds in any environmental
matrix does not necessarily mean that it is of concern or may cause
harm. However, major concerns arise from the detection of chem-
icals for which there is evidence that they may adversely affect
aquatic life [164]. The following sections summarise some of the
major concerns about the presence of PPCPs in the freshwater
aquatic environment.
1.1.1. Persistence
The physicochemical properties of many PPCPs, means that
many are not easily removed by conventional water treatment
processes, as demonstrated by their presence in drinking water
[147]. The inability to effect complete removal of PPCPs fromwaste
treatment plant poses a potential risk to aquatic organisms and
public health. The overwhelming evidence frommonitoring studies
is that PPCPs have found their way into the aquatic environment
and are ubiquitous [21]. The extensive nature of global PPCPs use,
coupled with the escalating introduction of new pharmaceuticals
to the market is contributing substantially to the environmental
presence of these chemicals and their active metabolites in the
aquatic environment [40]. Moreover, while not all PPCPs are
persistent, their continuous use and release to the environment
means many are considered “pseudo-persistent”. Pseudo-
persistent pharmaceuticals are suggested to have greater poten-
tial for environmental persistence than other organic contaminants
like pesticides, because their source continually replenishes even
when acted on by environmental processes such as biodegradation,
photodegradation and particulate sorption. Hence, pharmaceuti-
cals that may degrade would eventually and effectively behave as
persistent compounds because of their constant release into the
environment [76]. Lofﬂer et al. categorised 10 pharmaceuticals and
pharmaceutical metabolites into low, moderate and high persis-
tence compounds according to their dissipation time (DT50) in
water/sediment samples. Paracetamol, Ibuprofen, 2-
hyroxyibuprofen and CBZ-diol were classed as showing low
persistent (DT50 ¼ 3.1-7 days), Oxazepam, Iopromide and Iver-
mectin were deemed moderately persistent (DT50 ¼ 15-54 days)
while Cloﬁbric acid, Diazepam, Carbamazepine were rated highly
persistent (DT50 ¼ 119-328 days) [101]. A more recent study
demonstrated the anxiolytic drug (Oxazepam) to display extended
persistence in freshwater lakes due to past input and growing ur-
ban population [89].
1.1.2. Bioaccumulation
Although PPCPs are detected in the freshwater environment at
relatively low concentrations, many of them and their metabolites
are biologically active and can impact non-target aquatic organ-
isms. Several studies have examined the effect of PPCPs on non-
target organisms especially ﬁsh. The exposure of goldﬁsh (Car-
assius auratus) to waterborne gemﬁbrozil at an environmentallyrelevant concentration over 14 days resulted in a plasma bio-
concentration factor of 113 [114]. Another study by Ref. [160],
revealed bioaccumulation of the antiepileptic drug carbamazapine
(CBZ) by algae - Pseudokirchneriella subcapitata and the crustacean -
Thamnocephalus platyurus with bioaccumulation factors of 2.2 and
12.6 respectively. Furthermore [161], reported the uptake and
depuration of pharmaceuticals in reclaimed water by mosquito ﬁsh
(Gambusia holbrooki). The bioaccumulation factors measured for
caffeine, diphenhydramine, diltrazem, carbamazepine and
ibuprofen were 2.0, 16, 16, 1.4, and 28 respectively. Oxazepam was
detected at high concentrations in Eurasian perch ﬁsh with a bio-
accumulation factor of 12 [19]. Also [43] revealed the accumulation
of ﬂuoxetine in snails with the bioaccumulation factor of 3000 [42].
monitored 145 PPCPs in wild and caged mussels from the Grand
River, Ontario. Forty-three pharmaceuticals from different classes
were detected in mussel tissues, with bioaccumulation factors
ranging from 0.66 for metformin to 32 022 for sertraline.
As distinct from pharmaceuticals, PCPs have been detected in
algae which comprise the greatest abundance of plant biomass in
the aquatic environment. The lipid content of algae provides an
entry point for trophic transfer of lipophilic organic contaminants.
A study conducted by Ref. [38] detected the presence of two widely
used antimicrobial agents e triclocarban (TCC), triclosan (TCS) as
well as its metabolite methyl-triclosan (M-TCS) in algae samples
collected around a wastewater treatment plant (WWTP) in Texas.
Concentrations of target PCPs in water samples were low ranging
from 50 to 200 ng/L, while higher levels of 50e400 ng/g fresh
weight were detected in algae. The resulting bioaccumulation fac-
tors ranged from (700e1500), (900e2100) and (1600e2700) for M-
TCS, TCS and TCC respectively.
1.1.3. Toxicity
The major concern about the toxic implications of pharmaceu-
ticals (c.f. persistent organic pollutants such as PCBs (poly-
chlorinated biphenyls), PFASs (perﬂuoroalkyl substances) and
PBDEs (polybrominated diphenyl ethers)) is that they were
designed specifically to maximise their biological activity at low
doses and to target certain metabolic, enzymatic, or cell-signalling
mechanisms. The evolutionary conservation of these molecular
targets in a given species potentially increases the possibility that
these pharmaceuticals will be pharmacologically active in non-
target organisms. This mode of action (MoA) concept can be
applied to all aquatic biota, which are unintentionally exposed to
pharmaceuticals in their natural environment, thus raising the risk
of ecotoxicological effects [46]. The MoA conceptual frame work
was tested using the anti-depressant agent Fluoxetine, which tar-
gets the serotonin (5-HT) signaling pathway. Because 5-HT is a
high-tier physiological controller in aquatic organisms, alterations
of the 5-HT pathway by ﬂuoxetine had many adverse outcomes on
key physiological functions, including reproduction, metabolism
and locomotion in mussels at concentrations approaching or even
below environmental levels [60,61]. A major concern raised by the
presence of PPCPs in the aquatic environment is their ability to
interfere with the endocrine system to produce undesired effects/
disruption of homeostasis. The World Health Organization (WHO)
deﬁned endocrine disruptors (ED) as ‘exogenous substance or
mixture that alters function(s) of the endocrine system and
consequently causes adverse health effects in an organism, its
progeny or sub-population’. EDs include a vast group of chemicals
from natural (e.g. mycotoxins and phytoestrogens) and synthetic
origin (e.g. diethylstilbesterol (DES) and Bisphenol A) in varieties of
consumer products (e.g. PPCPs, cleaning products, antimicrobials,
food preservatives and phthalates) [166]. Endocrine disrupting
pharmaceuticals include sex hormones, glucocorticoids, veterinary
growth hormones and few non-steroidal pharmaceutical
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mixtures of PPCPs at low concentrations could lead to synergistic
interactions. This means that while individual PPCPs may be pre-
sent at low concentrations that do not elicit signiﬁcant toxic effects
when acting singly; PPCP mixtures can still exert considerable
ecotoxicity. This was demonstrated by Ref. [35]; whereby the
antiepileptic drug e carbamazepine and the lipid lowering agent
cloﬁbric acid (both belonging to different therapeutic classes)
exhibited much stronger effects to Daphnia magna than single
compounds at the same concentration [154]. also revealed that the
mixture effect of estradiol (E2) and 4-tert-nonylphenol (NP) can
give an additive/synergistic reaction, and consequently induce
vitellogenin production in juvenile rainbow trout. A study on the
brown trout, a salmonid species native to German rivers, investi-
gated the effect of diclofenac, one of the most prevalent pharma-
ceuticals in surface water. Results revealed that water-borne
diclofenac at levels of 5e50 mg/L affects kidney and gill integrity
and selected immune parameters in the ﬁsh [75]. A laboratory and
ﬁeld study conducted in France revealed that exposure to 17b-
estradiol on a freshwater ﬁsh; chub (Leuciscus cephalus) resulted in
a signiﬁcant and rapid increase in plasma vitellogenin (Vtg) in both
male and female chub [58]. Mimeault et al. also demonstrated that
exposure to waterborne gemﬁbrozil on goldﬁsh (Carssius auratus)
resulted in reduction on plasma testosterone by over 50% after 14Fig. 1. Summary of endocrdays [114].
Another important concern related to the presence of PPCPs in
the environment is the potential creation of antibiotic resistant
strains in natural bacterial populations. Extensive use of antibiotics
in human medicine and animal husbandry is the major cause for
the emergence and spread of antibiotic resistant bacteria, which
has become a threat to the effective prevention and treatment of
various infectious diseases caused by antibiotic-resistant patho-
genic bacteria [164]. Six antibiotics (ciproﬂoxacin, tetracycline,
ampicillin, trimethoprim, erythromycin and trimethoprim/sulpha-
methoxazole) detected in the efﬂuent of a WWTP in Australia
increased the resistance of 2 natural bacterial strains found in the
receiving waters [39]. Positive correlations have been found be-
tween antibiotic-resistant microorganisms and trace concentra-
tions of aquatic antibiotic contaminants [120]. Furthermore, the
presence of antibiotics could have a detrimental effect on naturally
occurring bacteria present in the environment. Speciﬁcally [41],
showed that even at sub-inhibitory concentrations, antibiotics may
still exert their biological impact on natural microbial communities
by inﬂuencing transcription in microbes. Some studies have re-
ported adverse effects on aquatic organisms including: toxicity of
ciproﬂoxacin to green algae [68], toxicity of oxolinic acid (a
commonly used feed additive in ﬁsh farms) to Daphnia magna, as
well as the toxicity of ﬂuoroquinolone antibiotics (ciproﬂoxacin,ine disrupting PPCPs.
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on ﬁve aquatic organisms, the cynobacterium; Microcystis aerugi-
nosa, duckweed; Lemna minor, the green alga; Pseudokirchneriella
subcapitata, the crustacean; Daphnia magna and fathead minnow;
Pimephales promelas [139].
Overall, the toxicity of PPCPs in the aquatic environment ex-
tends beyond the acute effects observed when therapeutic levels
are reached or exceeded. Recent studies have shown PPCP toxicity
to vary depending on the exposed organism, duration of exposure,
contaminant concentration, and developmental window at which
exposure occurs. Moreover, the effects of chronic trace-level
exposure, especially at certain sensitive stages of development,
are more likely to explain observed abnormalities within exposed
non-target organisms than acute high dose exposure [167]. As
many pharmaceutical contaminants are environmentally intro-
duced after human or veterinary use, metabolite concentrations
may be more signiﬁcant than that of parent compounds. For
instance, some acetylated metabolites of antibiotics (such as N4-
acetylsulfapyridine) were found to be more toxic than the parent
compound (sulfapyridine) in algae [62]. In addition, the presence of
active pharmaceutical agents under undesirable conditions in the
aquatic environment may alter their toxicological properties. To
illustrate, the photodegradation products of naproxen were re-
ported to have more toxic effects than the parent compound on
algae, rotifers, and microcrustaceans [82]. Acidic pharmaceutical
compounds may elicit different toxicological responses at different
pH levels in exposed non-target organisms [50] and metals shown
to accumulate in river bioﬁlms have been shown to increase the
toxicity of certain antibiotic contaminants (ﬂuoroquinolones and
tetracyclines) in an additive manner [182].Fig. 2. Illustration of sources of environ1.2. Environmental fate and behaviour of PPCPs
1.2.1. Sources
Post-use, many PPCPs ﬁnd their way into the environment
through different routes (Fig. 2). The major sources of PPCPs to the
environment are via sewage treatment plants (STPs) [40], WWTPs,
and landﬁll leaching. PPCPs are often not completely and consis-
tently removed during conventional wastewater treatment pro-
cesses, and thus are frequently detectable in reclaimed surface
water at concentrations ranging from ng/L to mg/L [30]. The
contamination of the freshwater environment with pharmaceuti-
cals can occur in various ways e an important pathway is absorp-
tion of PPCPs by the body following therapeutic use, followed by
excretion and release into the sewage system or septic tank. After
treatment of sewage, the wastewater may be used for irrigation
with the biosolids (treated sludge) potentially applied as fertilizer
to agricultural land [178]. Another source of PPCPs to the envi-
ronment is via their manufacture as the wastewater from the
production facility goes directly into STPs [57]. After treatment, the
sludge is deposited on the soil as fertilizer, with the liquid efﬂuent
discharged directly into the freshwater environment. In addition,
PPCPs can reach the groundwater through leaching from the soil
and this could pose a threat to drinking water. Not only that,
pharmaceuticals can also reach freshwater through run-off from
land treated with digested sludge for agricultural purposes [119].
Veterinary drugs are released into the environment when animal
wastes either in solid or liquid states are sprayed on agricultural
ﬁeld as fertilizers. These veterinary drugs together with their me-
tabolites pollute the soil and could enter the food chain. Conse-
quently, agricultural run-off can enter freshwater systems and
leach to groundwater [49]. Furthermore, externally applied PCPs
are mostly discharged through shower waste, bathing, swimming
and washing sinks. They can pass through WWTPs, and reach themental contamination with PPCPs.
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1.2.2. Transport
Once released into the environment, there is possibility of long
range transport of some PPCPs depending on the physicochemical
properties of the compound and the characteristics of the receiving
environment. PPCPs generally have low volatility and are highly
polar and hydrophilic in nature; therefore their distribution
through the environment will primarily occur through aqueous
transport and food chain dispersal [26]. Transport of PPCPs be-
tween different environmental media depends on the sorption
behaviour of the compound in treatment plants, soil, and thewater-
sediment system [17]. Several groups of PPCPs can be found in
sludge samples of STPs through adsorption. This creates a potential
pathway for PPCPs into the environment by direct release or
application of sludge to agricultural land as fertilizer [156]. A study
observed that PPCPs were transported into groundwater when
biosolids were applied onto agricultural land [70] as well as ﬁelds
irrigated with treated wastewater [129]. This resulted in the uptake
of PPCPs by crops, which may constitute a potential pathway of
human exposure to PPCPs through dietary intake [170,171]. Runoff
from biosolids containing PPCPs either from landﬁlls or applied on
agricultural land may be transported into the surrounding surface
water or leach into the groundwater [90], thereby posing a risk to
aquatic life and public health. Sorption in sediment is another
mechanism through which PPCPs are transported to the aquatic
environment. The sediment acts as a sink and accumulates these
environmental contaminants which may be released back to the
aquatic environment [183]. Several studies have shown some PPCPs
(e.g. sulfamethoxazole, carbamazepine, triclosan and ciproﬂoxacin)
to be more persistent in sediment than water [31,36]. Osenbruck
et al. identiﬁed local river water inﬁltration, sewer exﬁltration, and
urban stormwater recharge as the major sources of carbamazepine,
galaxolide, and bisphenol A in groundwater underlying the city of
Halle (Saale), Germany [126].
Nevertheless, the fact that adsorption to sediment or suspended
solids may inﬂuence concentrations of PPCPs in receiving water
does not necessarily result in a reduction of their bioavailability or
toxicity. Several studies have reported accumulation of PPCPs in
different environmental compartments including sediments
[8,29,145]. Therefore, there exists the possibility of continuous
release of these chemical compounds from sediments to overlying
water. This may have adverse effects on benthic organisms that are
continuously exposed to these chemicals within the sediments,
interstitial water and in overlying water [66]. Tamura et al. esti-
mated the combined contribution of triclosan, triclocarban and
galaxolide to total river sediment toxicity to be as high as 8.2% using
the benthic organism, Chironomus yoshimatsui [151]. Further un-
derstanding of the toxicological impacts of PPCPs in freshwater
sediments appears imperative as sediment acts as a sink for these
chemicals.
1.3. Environmental degradation and transformation
Biodegradation, photodegradation and other abiotic trans-
formation processes such as hydrolysis [14], may reduce concen-
trations of PPCPs in the environment and result in partial loss and
mineralization of these compounds [3].
The extent of photodegradation depends on the intensity of
solar irradiation, water depth, organic matter composition, eutro-
phic conditions, latitude and seasonality. A study conducted by
Ref. [32]; revealed that under artiﬁcial estuarine water condition, a
photodegradation product of carbamazepine is acridine. This
metabolite has shown to be toxic, mutagenic and carcinogenic.
Another study suggested that tetracycline, an antibiotic usedwidely for animal husbandry, cannot be photodegraded because of
its adsorption onto sediment [155]. However, the analgesic diclo-
fenac could be easily and rapidly degraded through direct photol-
ysis with a (pseudo) ﬁrst-order elimination rate and a short half-life
of <1 h [23] [140]. reported 11e68% of propranolol was removed by
photodegradation in US rivers and predicted removal of up to 27%
in the River Aire, UK, during the summer. Similar results were re-
ported for Ibuprofen, Metronidazole, Acetaminophen and several
other PPCPs, suggesting photolysis as one of the major degradation
pathways of PPCPs in surface waters [15,27].
Biodegradation stems from the reaction with natural microbial
ﬂora in the environment. Many PPCPs undergo microbial mediated
reactions during WWT processes [72] and in the environment,
resulting in the formation of transformation products. Oenesois
et al. provided a comprehensive review on biodegradation and
removal of PPCPs in treatment systems. They concluded that
accurately predicting biodegradability based on a PPCP's intended
function may not be possible. Since biodegradation involves
enzymatic reactions speciﬁc to chemical structures, the biode-
gradability of PPCPs with different structures grouped in the same
therapeutic class is expected to vary, thwarting efforts to observe
general trends [125]. Microorganisms that utilize PPCP substrates
at certain concentration either as a carbon or energy source would
be expected to increase in microbial growth and thereby resulting
in further degradation of PPCPs. However, the increase in PPCP
concentrations could inhibit biodegradation, therefore becoming
toxic to the natural occurring microorganisms. Despite an initial
increasing trend of degradation up to concentrations of 100 mg/L;
none of the studied PPCPs including 4-isopropyl-3-methylphenol
(biosol), p-chloro-m-xylenol, gemﬁbrozil, ketoprofen, and
phenytoin achieved their highest degradation at the highest
respective concentration of 1000 mg/L, thereby suggesting enzyme
saturation at such high concentrations [124].
During waste water treatment (WWT), transformation of PPCPs
may occur depending on the physicochemical properties of the
compound and the conditions of the WWT. During the process,
PPCPs may be completely destroyed, or partially transformed to
metabolites or in some instances left unchanged [172]. It is
important to bear in mind that the breakdown or removal of the
parent compounds during WWT does not necessarily mean the
removal of toxicity, it is expected that a great number of trans-
formation products with unknown toxicity and persistence may
still be present in the ﬁnal efﬂuent as well as in receiving water
bodies [80]. Typical examples of the transformation of pharma-
ceuticals are presented below for the anti-inﬂammatory/analgesic
ibuprofen, the X-ray contrast media diatrizole and an antihyper-
tensive drug (valsartan).
[187] used a bioﬁlm reactor (BFR) and batch experiment with
activated sludge (BAS) to study the transformation of ibuprofen.
The result revealed hydroxyibuprofen (OH-Ibu) to be the major
metabolite of ibuprofen under oxic conditions and carboxyhyra-
tropic acid (CA-HA) under anoxic conditions. Moreover, carbox-
yibuprofen (CA-Ibu) was identiﬁed as a major metabolite under
both oxic and anoxic conditions. These transformation products
either generated by human metabolism or by microorganisms
present in the WWTPs and in the natural environment may in-
crease the probability of their environmental presence [51].
In contrast to ibuprofen, diatrizole does not metabolize and is
excreted unchanged. In WWTPs, it has been shown to be persistent
under aerobic conditions. Therefore, diatrizole has been detected at
elevated concentrations in the efﬂuents of WWTPs, surface water,
groundwater and even in ﬁnished drinking water [136].
[72] reported on the transformation of valsartan. The trans-
formation products formed followed a sequence of transformation
steps. The ﬁrst reaction was an N-dealkyation reaction, yielding
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formed to amino-valsartan by an amide hydrolysis reaction and
subsequently another transformation product was formed [2'-(1H-
tetrazol-5-yl)biphenyl-4-yl]acetaldehyde (otherwise referred to as
valsartan acid), through the hydrolysis and oxidation of amino-
valsartan. These transformation products were suggested to pro-
vide the rationale for the environmental persistence of valsartan.
1.4. PPCPs in the freshwater aquatic environment
The environmental occurrence of pharmaceuticals was ﬁrst re-
ported in Kansas City, US in 1976, where cloﬁbric acid was detected
in treated wastewater at concentrations ranging from 0.8 to 2 mg/L
[50]. Subsequently [137], investigated the presence of 25 pharma-
ceuticals in the river Lee (a source of potable water for North
London) with concentrations up to 1 mg/L in 1981. Since then,
several studies have detected PPCPs in different environmental
compartments across the globe [74,92,134]. Despite the fact that
reported concentrations of these PPCPs are low;many of them have
the potential to persist in the natural environment for months to
years [16]. The detection of pharmaceuticals in the environment
varies not only between countries but also between different re-
gions of the same country. That is to say, detectable pharmaceuti-
cals in one country or region may not appear in other countries/
regions where they are not highly prescribed [83]. This precludes
meaningful global comparison of PPCPs levels due to variations of
the targeted compounds and detected chemicals in each reported
study. For instance, we compared the reported concentrations of
NSAIDs in surface water from different countries (Fig. 3). While this
ﬁgure may provide indicative information on the global contami-
nation levels, it should be studied carefully because studies from
different countries have targeted and/or detected different mem-
bers of the NSAIDs group. Therefore, concentrations of different
classes of PPCPs reported in the freshwater aquatic environment
from each continent will be reviewed separately in the next section.
1.5. Europe
1.5.1. Wastewater and surface water
Richardson and Bowron reported the presence of 25 pharma-
ceuticals inwater samples taken in 1981 from the river Lee, UKwith
concentrations of dextropropoxyphene, erythromycin,Fig. 3. Concentrations (ng/L) of non-steroidal anti-inﬂammatory drugs (NSAIDs)* reported
* NSAIDs include Ibuprofen, Naproxen, Diclofenac, Ketoprofen and Acetaminophen.
** Data from [116], [86], [85], [87], [144], [18], [111], [112], [177], [122], [52], [165], [23], [24sulphamethoxazole, tetracyclin and theophylline up to 1 mg/L [137].
Subsequently, a study in German municipal STPs and rivers,
investigated 32 pharmaceuticals from different classes including
antiphlogistics, lipid regulators, psychiatric drugs, antiepileptic
drugs, betablockers and b2-sympathomimetics in discharged ef-
ﬂuents, stream and river waters. More than 80% of the selected
drugs were detectable in at least one municipal STP efﬂuent with
concentrations of carbamazepine up to 6.3 mg/L with resultant
contamination of the receiving waters. The lipid regulator “beza-
ﬁbrate” showed the highest concentration of 3.5 mg/L in the
sampled river waters [152]. Concentrations of ibuprofen detected in
inﬂuent and efﬂuent samples from various German WWTPs dis-
played amaximumof 3.5 and 0.3 mg/L respectively [81]. Hirsch et al.
investigated STP efﬂuents and random river water samples
collected in Germany for the presence of antibiotic residues. The
results showed frequent detection of erythromycin, roxithromycin
and sulfamethoxazole at concentrations up to 6 mg/L [74]. Another
German study [52] reported detection of 6 pharmaceuticals: car-
bamazaepine, cloﬁbric acid, diclofenac, propranolol and sulfa-
methoxazole at concentrations 6.3, 1.6, 2.1, 0.29 and 2 mg/L in
efﬂuent and 1.1, 0.55, 1.2, 0.59, and 0.48 mg/L in surface water,
respectively. In addition, carbamazepine, diclofenac, ibuprofen, as
well as a variety of antibiotics and lipid regulators were detected in
water samples collected from the River Elbe in 1998 at concentra-
tions ranging between 20 and 140 mg/L [165]. Moreover, a study
examined the fate of triclosan and its active transformation prod-
uct, triclosan-methyl in STPs and surface water (River Ruhr) in
Northern Germany. Concentrations of both compounds ranged
between <3 and 10 ng/L for triclosan and between 0.3 and 10 ng/L
for triclosan-methyl [13].
In the UK, Hilton et al. detected mefenamic acid, diclofenac,
propranolol, erythromycin, trimethoprim and acetyl-
sulfamethozole in both efﬂuent samples and surface water
sampled downstream of efﬂuent discharge [73]. Ashton et al.
investigated efﬂuent and surface water samples from Corby, Great
Billing, East Hyde, Harpenden and Ryemeads STPs in the UK. Ten
pharmaceuticals were detected in the STP efﬂuent samples: pro-
pranolol (detection frequency ¼ 100%, median ¼ 76 ng/L), diclo-
fenac (86%, 424 ng/L), ibuprofen (84%, 3086 ng/L), mefenamic acid
(81%,133 ng/L), dextropropoxyphene (74%,195 ng/L), trimethoprim
(65%, 70 ng/L), erythromycin (44%, <10 ng/L), acetyl-
sulfamethoxazole (33%, <50 ng/L), sulfamethoxazole (9%, <50 ng/in surface water samples from different countries**.
], [67], [33], [7].
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streams, fewer compounds and lower concentrations were found
[6]. Another study conducted in the UK by Ref. [153] detected clo-
ﬁbric acid, clotrimazole, dextropropoxyphene, diclofenac,
ibuprofen, mefenamic acid, propranolol, tamoxifen, and trimetho-
prim at measurable concentrations inwater samples collected from
the lower reaches of the rivers Tyne, Tees, Mersey, and Thames as
well as Belfast Lough in the UK. Clotrimazole appeared to be the
most frequently detected in 59% of all the samples collected at a
maximum concentration of 22 ng/L and a mean concentration of
7 ng/L [138]. surveyed wastewater efﬂuent and surface waters of
the lower River Tyne, UK. Out of 9 compounds analyzed in the raw
efﬂuent samples, sulfamethoxazole and acetyl-sulfamethoxazole
were detected at concentrations ranging from 11 to 69 570 ng/L.
In surface water samples, clotrimazole, dextropropoxyphene,
erythromycin, ibuprofen, propranolol, tamoxifen and trimethoprim
were detected at concentrations ranging from 4 to 2370 ng/L.
In the South Wales, UK [86], reported the contamination of the
River Taff and the River Ely with PPCPs, illicit drugs and other
endocrine disruptors, which was attributed mainly to the extensive
discharge of treated wastewater efﬂuent into the rivers. The
investigation suggested that the most frequently detected PPCPs
represent the compounds that are highly dispensed in the Welsh
community. These include: anti-inﬂammatories/analgesics (tra-
madol, codeine, paracetamol, naproxen, ibuprofen and diclofenac),
antibacterial drugs (erythromycin, trimethoprim and amoxicillin)
and antiepileptic drugs (gabapentin and carbamazepine). Some of
these PPCPs (e.g. codeine, erythromycin, valsartan, gabapentin and
carbamazepine) were found to be ubiquitous and persistent in the
aqueous environment. Illicit drugs were also detected in both rivers
at low concentrations. The average daily loads of amphetamine,
cocaine and its main metabolite benzoylecgonine were reported at
8, 1 and 39 g/day respectively.
[185] also reported PPCPs such as: propranolol, sulfamethoxa-
zole, carbamazepine, indomethacine and diclofenac were
frequently detected in wastewater and river water sampled from
three WWTPs in England and the River Ouse. Carbamazepine
showed the highest concentrations (up to 2336 ng/L) in WWTP
inﬂuent samples. Interestingly [93], reported as the presence of
glucocorticoids (GCs) in the river Thames, in the UK. The total
concentrations of 28 GCs ranged between 30 ng/L and 850 ng/L.
These concentrations were much higher than those of more
extensively studied estrogens especially ethinylestradiol and other
steroid hormones. At such concentrations, adverse effects on
aquatic organisms are possible. However, Baker and Kasprzyk-
Hordern went further to report occurrence of a comprehensive
set of drugs of abuse in river water, untreated and treated waste-
water in England, UK. They identiﬁed the top ten pharmaceuticals
with the highest median concentration detected from the WWTPs
inﬂuent and efﬂuent to be: caffeine (23 778.4 ng/Le1744.2 ng/L), 1,7
dimethylxanthine (20 400.4 ng/Le1219.8 ng/L), nicotine
(3919.3 ng/Le85.7 ng/L), codeine (1255.9 ng/Le372.2 ng/L), tra-
madol (1122.6 ng/Le738.7 ng/L), ephedrine (476.2 ng/Le35.0 ng/L),
nortramadol (397.0 ng/Le144.8 ng/L), morphine (371.2 ng/
Le59.1 ng/L), dihydrocodeine (226.6 ng/Le118.2 ng/L), and
amitriptyline (206.3 ng/Le66.3 ng/L) respectively. Similar high
median concentrations of these pharmaceutical compounds were
observed in river water samples collected both upstream and
downstream of the WWTPs [10].
Furthermore [184], reported the occurrence of pharmaceuticals
in samples collected from the River Medway, UK in February 2010.
Concentrations in water sampled for upstream sewage efﬂuent and
efﬂuent discharge sites were: propranolol (8e35 ng/L), meso-bili-
verdin (3e11 ng/L), thioridazine (6e22 ng/L), carbamazepine
(53e265 ng/L), tamoxifen (2e8 ng/L), indomethacine (6e28 ng/L),andmeclofenamic acid (28e176 ng/L). The highest concentration of
all studied compounds was for diclofenac in the efﬂuent discharge
site (543 ng/L). Apart from the water samples analysed, high con-
centrations of pharmaceuticals were also detected in all solid res-
idue samples in the month of June 2010 with the highest
concentrations being: diclofenac (58.7 ng/g), carbamazepine
(46.5 ng/g), indomethacine (42.6 ng/g), and meclofenamic acid
(37.3 ng/g).
Buser et al. identiﬁed cloﬁbric acid concentrations found in
various Swiss lakes (the Zurichsee, the Sempachersee and the
Greifensee) fell in the range of 1e9 ng/L [22]. Buser et al. also
studied the occurrence and fate of diclofenac in Swiss lakes and
rivers. The concentrations in the lakes ranged from <1 to 12 ng/L,
while the highest concentration (11e310 ng/L) were observed in
the river Aabach, one of the major inﬂows of Lake Greifensee [23].
In 1999, the same research group investigated the presence and
behaviour of ibuprofen in surface and wastewater samples. Surface
water samples were collected from lakes and rivers in Switzerland
and from the North Sea, with wastewater samples collected from
the SwissWWTPs of Gossau, Pfafﬁkon and Uster. The concentration
of ibuprofen in the inﬂuents of the WWTPs was up to 3 mg/L while
in the river and lakes, ibuprofen was detected at concentrations up
to 8 ng/L [24].
Carbamazepine, atenolol, metoprolol, sulfametoxazole, gemﬁ-
brozil and propanolol were detected and demonstrated a high
degree of persistence in the Hoje River in Sweden, at concentra-
tions ranging from 0.16 to 1.18 mg/L [12]. In a wide survey of more
than 100 individual water samples from over 100 European rivers
from 27 European countries, Loos et al. identiﬁed persistent phar-
maceuticals as benzotriazole, caffeine and carbamazepine to be the
most frequently detected and at the highest concentration levels
[103]. A study in Catalonia, Spain also determined the presence of
11 PPCPs in both surface water (Ebro and Llobregat River) and
wastewaters with benzophenone-3 having the highest concentra-
tion (7 ng/L) [130]. Another study reported the occurrence and
distribution of multi-class pharmaceuticals, their active metabo-
lites and transformation products in the Ebro River basin in Spain.
Out of 77 target analytes, the compounds found to be ubiquitous
were carbamazepine, clarithromycin, sulfadiazine, propranolol,
tamoxifen and salicylic acid. The highest concentration of 1667 ng/L
was detected for the carbamazepine metabolite (10,11 epoxi-
carbamazepine) in a small tributary, the Zadorra river [104].
Calamari et al. reported the detection of therapeutic agents such
as atenolol, lincomycin, erythromycin, clarithromycin, bezaﬁbrate
and furosemide in the River Po and Lambro, Northern Italy at
concentration ranging from 0.1 to 250 ng/L [25]. A study in Portugal
revealed the presence of pharmaceutical active compounds (mostly
nonsteroidal anti-inﬂammatory drugs) ranging from 0.050 to
100 mg/L in the inﬂuent and up to 50 mg/L in the efﬂuent of 5
WWTPs. Musks were also detected at concentrations of 11.5 mg/L,
0.9 mg/L and 22.6 mg/L in the inﬂuent, efﬂuent and sludge respec-
tively [141]. Furthermore [110], monitored seasonal variation of 15
pharmaceuticals during four seasons (February, May, July and
November 2010) along a wastewater polluted watercourse, River
Rakkolanjoki and Lake Haapajarvi in Eastern Finland. The concen-
trations ranged from 0 to 556 ng/L. Out of the 15 studied com-
pounds, carbamazepine had the highest concentrations and was
not eliminated during any of the seasons.
1.5.2. Sediment and sewage sludge
Several studies have shown that pharmaceuticals consumed in
large quantities have been detected in the aqueous environment
particularly in sediment. Lofﬂer and Ternes reported the detection
of acidic pharmaceuticals and their metabolites (cloﬁbric acid,
diclofenac, fenoprofen, gemﬁbrozil, ibuprofen, 2-hydroxy-
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(clarithromycin, erythromycin, roxithromycin, sulfadiazine, sulfa-
methazine, sulfamethoxazole and trimethoprim) and parasiticide
ivermectin in sediment from the Wickerbach creek, close to
Frankfurt, Germany [102]. Martin et al. investigated pharmaceuti-
cals in sewage sludge, compost as well as sediment samples
collected from the surface water of Guadiamar River in Seville,
Southern Spain. The pharmaceuticals detected in the sediment
were naproxen, salicylic acid, propranolol, caffeine and 17a-ethi-
nylestradiol at concentrations of 11.2, 9.49, 3.37, 7.21, and 48.1 mg/kg
respectively [108]. A more recent study examined sediment sam-
ples collected along four representative Iberian River basins; Llo-
bregat, Ebro, Jucar and Guadalquivir, Spain. The most widely spread
and highly concentrated pharmaceuticals were hydrochlorothia-
zide (3 ng/g), gemﬁbrozil (6 ng/g), tetracyclines (6 ng/g), codeine
(12 ng/g) azithromycin (24 ng/g), and ibuprofen (13 ng/g) [127].
Varga et al. investigated selected acidic pharmaceuticals:
ibuprofen, naproxen, ketoprofen and diclofenac in the Danube river
water and sediment in Budapest, Hungary. In the river water,
ketoprofen was always below the LOQ, while ibuprofen, naproxen
and diclofenac were quantiﬁed in the range of 8e50, 2e30,
7e90 ng/L. In sediments, only naproxen and diclofenac were found
in the range of 2e20 and 5e38 ng/g, respectively [157]. Concen-
trations of human pharmaceuticals, illicit drugs, and bactericides
were reported in Scottish sediments and sludge samples. None of
the illicit drugs and metabolites were detected but triclosan (up to
5940 ng/g) and triclocarban (up to 2829 ng/g) were [94]. The study
concluded that the drug content of sediment depended on its
concentration in the aqueous phase and the total organic carbon
content of the sediment.1.5.3. Biota
Globally, studies have shown that exposure to WWTP efﬂuents
containing PPCPs is associatedwith a range of deleterious effects on
the reproduction in aquatic organisms [65]. revealed bio-
accumulation of a mixture of estrogenic contaminants in ﬁsh tis-
sues, thereby resulting in the induction of vitellogenin and possibly
contributing to feminization of wild ﬁsh residing in UK rivers.
Pojana et al. examined natural and synthetic endocrine-disrupting
chemicals (EDCs) inwater, sediment and biota of a coastal lagoon in
Venice. The result of their study showed that most of the selected
compounds were found in water and sediment at concentration
ranging from 2.8 to 211 ng/L and 3.1e289 mg/kg dry weight
respectively. The compounds detected in theMediterraneanmussel
(Mytilis galloprovincialis) were 17a-ethinylestradiol and non-
ylphenol at concentration range 7.2e240 ng/g in dry weight [132].
In another study by Ref. [56]; in which rainbow trout were exposed
to pharmaceutical sewage efﬂuents, levonorgestrel was accumu-
lated in ﬁsh blood at concentrations of 8.5e12 ng/ml.
Subedi et al. measured galaxolide and tonalide in tilapia and
bream ﬁsh samples collected from Rhine River, Germany at con-
centrations of 81 and 5.5 ng/g wet weight respectively [150].
Alvarez-Munoz et al. investigated the presence of pharmaceuticals
in oyster, clam and mussel samples collected from the Ebro delta,
Spain. The results revealed the most ubiquitous compounds
detected were the psychiatric drug venlanfaxine and the antibiotic
azithromycin, with the highest concentrations found in mussels
(2.7 ng/g) and oysters (3.0 ng/g) [4]. Another Spanish study
examined residual pharmaceuticals in pork, veal, lamb and chicken
muscle, liver and kidney as well as salmon, sea bass and sole ﬂesh
purchased at a local supermarket. The study revealed the most
frequently detected analytes were the hormones estrone and 17b-
estradiol and the antibacterials ﬂorfenicol and pyrimethamine [9].1.6. North and South America
1.6.1. Wastewater and surface water
In a seminal study, concentrations of pharmaceuticals were re-
ported in Kansas City, US in 1976 in treated wastewater, with clo-
ﬁbric acid present at concentrations ranging from 0.8 to 2 mg/L [50].
In South America, Stumpf et al. detected polar drugs residues in
sewage and natural waters in the state of Rio de Janeiro, Brazil. In
surface water, cloﬁbric acid, diclofenac and naproxen were
frequently detected at low concentrations (0.01e0.06 mg/L) in the
major river used for drinking water production [149].
[79] reported estrogenic hormones in efﬂuent from four
municipal WWTPs efﬂuent in California, USA, as well as in surface
water from a wetland receiving such efﬂuent, namely the Colorado
River and the Sacramento River delta. Median concentrations in the
wastewater efﬂuents were 1.9 ng/L and - 0.6 ng/L for 17b-estradiol
(E2) and 17a-ethinylestradiol (EE2), respectively. Median concen-
trations in surface water were 0.08 ng/L and > 0.05 ng/L for E2 and
EE2.
[92] detected various pharmaceuticals in samples from a
network of 139 streams susceptible to contamination (i.e. down-
stream of urban areas and livestock production) across 30 states
during 1999 and 2000. The most frequently detected compounds
were coprostanol (fecal steroid), cholesterol (plant and animal
steroid), N,N-diethyltoluamide (insect repellent), caffeine (stimu-
lant), triclosan (antimicrobial disinfectant), tri (2-chloroethyl)
phosphate (ﬂame retardant), and 4-nonylphenol (nonionic deter-
gent metabolite). Measured concentrations for this study were
generally low and rarely exceeded drinking water guidelines,
drinking water health advisories, or aquatic life criteria. Boyd et al.
investigated the presence of PPCPs in surface water and treated
waters of Louisiana, USA and Ontario, Canada. The study revealed
that naproxenwas detected in Louisiana STP efﬂuent at 81e106 ng/
L and in Louisiana (Mississippi River) and Ontario (Detroit River)
surfacewaters at 22e107 ng/L [18]. Another study inMontana, USA,
reported detection of sulfamethoxazole, atrazine, carbamazepine,
dilantin and diclofenac with maximum concentrations of 490 ng/L,
130 ng/L, 420 ng/L, 22 ng/L and 46 ng/L respectively in ground
water [113]. Batt et al. reported the presence of some antibiotics in
receiving streams impacted bywastewater discharge in East Aurora
and Holland, New York. Ciproﬂoxacin, sulfamethoxazole and clin-
damycin (0.043e0.076 mg/L) were detected 100 m from the
discharge point [11].
A study of the Mississippi in New Orleans, Louisiana, USA,
revealed contamination by PPCPs including: cloﬁbric acid
(3e27 ng/L), ibuprofen (<1e34 ng/L), acetaminophen (25e65 ng/L),
caffeine (<1e38 ng/L), naproxen (<1e135 ng/L), triclosan (9e26 ng/
L), bisphenol A (<1e147 ng/L), carbamazepine (43e114 ng/L),
estrone (<1e5 ng/L) and 17b-estradiol (<!-5 ng/L) at the following
concentrations [181]. A study of a major receiving river, the Chop-
tank in Maryland, USA, revealed the presence of various antibiotics
and hormones at different concentrations in a major agricultural
watershed. The most frequently detected antibiotic in the river
were sulfamethoxazole and sulfadimethoxine at concentrations
ranging from 0.005 to 0.007 mg/L [5].
Wu et al. reported the occurrence of selected pharmaceuticals in
an agricultural landscape, western Lake Erie basin in northern Ohio.
The results showed that the most frequently detected compounds
were caffeine, carbamazepine, ibuprofen and paraxanthine at
maximum concentrations of 4.2, 1.2, 2.8 and 1.8 mg/L [169]. Another
study examined the distribution and temporal trends of 19 PPCPs
including 11 hormones in two WWTPs from Charleston, SC, USA
over a period of one year. Acetaminophen, caffeine and ibuprofen
showed the highest concentrations in both WWTPs samples, fol-
lowed by triclosan and triclocarban. In Charleston Harbour surface
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98.6%, 33.3%, and 22.2% of samples respectively [71] [14]. also re-
ported detection of 32 pharmaceuticals in Lake Michigan water,
with 30 detected in the sediment. Among those most frequently
detected were: metformin, caffeine, sulfamethoxazole and
triclosan.
A study in Cape Cod, Massachusetts, USA, reported most
frequently-detected pharmaceuticals including sulfamethoxazole,
the anticonvulsant phenytoin, and carbamazepine at maximum
concentrations of 113 ng/L, 66 ng/L and 72 ng/L, respectively inwell
water [142]. Fairbairn et al., also reported the detection of PPCPs
(detection frequencies and median concentration in parentheses) such
as atrazine (99%, 29 ng/L), caffeine (97%, 17 ng/L), metolachlor (88%,
10 ng/L), acetaminophen (88%, 3.3 ng/L), DEET (87%, 16 ng/L) and
trimethoprim (72%, 5.9 ng/L) in 68 grab water samples from the
Zumbro River watershed, Minnesota, USA at concentrations over a
period of one year [47].
Metcalfe et al. reported the occurrence of neutral and acidic
drugs in the efﬂuents of Canadian STPs. The study showed that lipid
regulators such as bezaﬁbrate and gemﬁbrate were detected in
some inﬂuent and efﬂuent samples as well as carbamazepine at
concentrations as high as 2.3 mg/L [111]. To determine the distri-
bution of acidic and neutral drugs in surface waters near STPs in the
lower Great Lake, Metcalfe and colleagues examined surface water
collected from Lake Ontario and Lake Erie and STPs efﬂuents. The
result shows detection of all the acidic drug analytes except keto-
profen in the efﬂuents. However, ibuprofen and gemﬁbrozil were
detected in STP efﬂuents at concentrations >1 mg/L [112]. Verenitch
et al. also reported the presence of acidic drugs and caffeine in
municipal wastewaters and receiving water on the west coast of
Vancouver Island, British Columbia, Canada. Ibuprofen, naproxen as
well as salicylic acid were detected in the samples of STP waste-
water and also in surface water samples collected near STP outfalls
[159]. Concentrations of pharmaceuticals and s-triazine herbicides
were determined inwastewater efﬂuent and surfacewater sampled
from the upper Detroit River, Canada. 15 pharmaceuticals including
carbamazepine, cotinine, caffeine, trimethoprim, ﬂuoxetine were
detected in the WWTP efﬂuent at concentrations ranging from 1.7
to 1244 ng/L [78].
Gibson et al. investigated reuse of wastewater for irrigation from
the Tula Valley in Mexico. The study revealed wastewater used for
irrigation to contain pharmaceuticals and potential endocrine dis-
ruptors. Ibuprofen (742e1406 ng/L), naproxen (7267e13589 ng/L),
and diclofenac (2052e4824 ng/L) were consistently present while
other pharmaceuticals such as gemﬁbrozil, cloﬁbric acid and
ketoprofen were below LOD [64].
[53] revealed the presence of ibuprofen in both inﬂuent and
efﬂuent from WWTPs at Penha and Ilha do Governador, Rio de
Janeiro, Brazil. Ibuprofen was detected in all samples analyzed,
conﬁrming low removal efﬁciency of conventional treatment
plants. Another study by same author [54] investigated psychiatric
pharmaceuticals in Guandu River, Rio de Janeiro, Southern Brazil.
The study revealed the presence of benzodiazepines such as bro-
mazepam, clonazepam and diazepam in all samples of surface
water at maximum concentrations of 42 ng/L, 198 ng/L, and 335 ng/
L respectively. In a comparative study conducted by the Minnesota
Pollution Control Agency, DEET, cotinine, lopamidol, bisphenol A,
metformin and the steroidal hormone androstenedione were
frequently detected in lake water at maximum concentrations of
103, 42, 510, 36, 18 and 5 ng/L. Overall, in surface water, sixteen
chemicals including some antidepressants, antibiotics and antihy-
pertensive pharmaceuticals were detected downstream of the
WWTPs, while six out of 56 target PPCPs such as Bisphenol A (BPA),
carbadox, ﬂuoxetine, sulfamethozine, virginiamycin, methylpred-
nisolone, moxiﬂoxacin and triclosan were detected frequentlyupstream [55]. Elsewhere [44], reported caffeine to be present in
surface water in Barbados at concentrations ranging from 0.1 to
6.9 mg/L.
1.6.2. Sediment and sewage sludge
The occurrence of PPCPs in freshwater sediment has been
documented by several authors. Sediment samples collected from
rivers (Mississippi, Sauk, South Fork of the Crow and Grindstone),
creeks (Center, Okabena) and lakes (Pepin, Superior, Shagawa) in
Minnesota, US, revealed a high level of triclocarban in freshwater
sediments at concentration up to 822 ng/g [158]. A study conducted
by Yang et al. investigated pharmaceuticals and organochlorine
pesticides in sediments from the Alaﬁa River in Florida, USA. The
most frequently detected compounds were carbamazepine, acet-
aminophen, diphenhydramine, trimethoprim, caffeine, nicotine,
lidocaine and ephedrine at concentrations ranging from 0 to 33 ng/
g [177]. Analysis of surface water, sediment and mussel samples
collected from San Francisco Bay, California, an urban estuary that
receives direct discharge from 40 municipal and industrial waste-
water outfalls, revealed the predominant compounds to be: tri-
clocarban in sediment, valsartan in surface water and DEET in
mussels at concentrations of 33 ng/g, 92 ng/L and 14 ng/g respec-
tively [91].
1.6.3. Biota
A national pilot study in the US, assessed accumulation of PPCPs
in ﬁsh sampled from ﬁve efﬂuent-dominated rivers receiving direct
discharge from wastewater treatment in Illinois, Texas, Florida,
Arizona, and Pennsylvania. The study revealed the presence of
galaxolide and tonalide in ﬁsh ﬁllets at every efﬂuent-dominated
site with maximum concentrations ranging from 300 to 2100 ng/
L and 21e290 ng/L respectively. The pharmaceuticals detected both
in liver and ﬁllets include: diphenhydramine, norﬂuoxetine, ser-
traline, diltiazem, carbamazepine, ﬂuoxetine, gemﬁbrozil, with
sertraline the most abundant at a maximum concentration in ﬁllet
and liver tissue of 19 and 545 ng/L respectively [134]. The same
research group also reported concentrations of diphenhydramine,
diltiazem, carbamazepine and norﬂuoxetine detected in muscle
tissues from ﬁsh collected in Pecan Creek, Denton County Texas,
USA. The concentrations ranged from 0.66 to 1.32, 0.11e0.27,
0.83e1.44, 3.49e5.14 ng/g respectively [135]. Mottaleb et al. used
two screening methods to determine 10 extensively used PCPs and
2 alkylphenol surfactants in ﬁsh ﬁllets collected from a regional
efﬂuent-dominated stream in Texas, USA. Benzophenone, galax-
olide, tonalide and triclosan were detected in all environmental
samples at concentrations ranging from 37 to 90, 234e970, 26e97
and 17e31 ng/g respectively [117].
Foltz et al. quantiﬁed selected nitromusks, antimicrobial agents
and antihistamines in edible frozen retail fresh and salt water ﬁsh
ﬁllets in Maryville, Missouri, USA. The compounds consistently
detected were galaxolide, tonalide, triclosan and diphenhydramine
at concentrations ranging from 0.163 to 0.892, 0.068e0.904,
0.189e1.182 and 0.942e7.472 ng/g respectively. Musk ketone was
not detected in any of the ﬁsh studied [59]. A report by Brooks et al.
revealed pharmaceutical accumulation in ﬁsh of efﬂuent-
dominated streams in North Texas, USA. The study showed the
selective serotonin reuptake inhibitors (SSRI) ﬂuoxetine and ser-
traline, in addition to their metabolites norﬂuoxetine and desme-
thylsertraline to be detected at concentrations > 0.1 ng/g in all ﬁsh
tissues examined [20]. Schultz et al. investigated the occurrence
and fate of antidepressant pharmaceuticals in surface water, sedi-
ment, and native white sucker (Catostomus commersoni) samples
collected from Boulder Creek, (Colorado) and Fourmile Creek
(Iowa). Fluoxetine, sertraline, and their degradates were the prin-
cipal antidepressants observed in ﬁsh brain tissue, typically at low
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uptake of human pharmaceuticals in bull sharks (Carcharhinus
leucas) inhabiting the wastewater impacted Caloosahatchee River.
Compounds detected in the plasma of Caloosahatchee River sharks
were: 17a-ethyinestradiol, citalopram, ﬂuoxetine, ﬂuvoxamine,
paroxetine, sertraline and venlafaxine at concentrations ranging
from 0.10 to 6.25 [63].
1.7. Asia
1.7.1. Wastewater and surface water
Yamagishi et al., detected musk xylene and musk ketone (syn-
thetic musks) in 100% and 80% respectively of 74 samples from
Tama River and Tokyo Bay in Japan [175]. Elsewhere, the levels and
distribution of 12 antimicrobials were investigated in water from
the Mekong Delta, Vietnam and compared with those in the Tam-
agawa River, Japan. While a few compounds such as sulfamethox-
azole, sulfamethazine, trimethoprim and erythromycin-H2O were
detected in Vietnam at concentrations between 7 and 360 ng/L,
while more antimicrobials were found in the Japanese urban river
including: sulfamethoxazole, sulfapyridine, trimethoprim, eryth-
romycin-H2O, azithromycin, clarithromycin, and roxithromycin at
concentrations ranging from 4 to 448 ng/L [107]. A study by
Ref. [95] investigated the efﬂuent from a WWTP impacted by drug
manufacturing in Patancheru, near Hyderabad, India. Extremely
high concentrations of pharmaceuticals, such as ciproﬂoxacin up to
31 mg/L were measured in the efﬂuent. Moreover [57], reported a
severe case of contamination of surface, ground and drinking water
with pharmaceuticals in the Patancheru industrial area in India.
Compounds detected included: 1.2 mg/L of cetrizine and 6.5 mg/L
of ciproﬂoxacin, in addition to several other pharmaceuticals
detected at mg/L levels.
Choi et al. examined the concentrations of several pharmaceu-
tical residues in surface water of the Han River, Korea. The con-
centrations of the target compounds such as cimetidine, caffeine,
acetaminophen, and sulfamethoxazole detected in the surface
water were 281, 268.7, 34.8 and 26.9 ng/L respectively [34]. Another
study [87]; detected several pharmaceuticals including: ibuprofen
(nd to 414 ng/L), carbamazepine (nde595 ng/L), atenolo (nd-
690 ng/L), clarithromycin (nd-443 ng/L), mefenamic acid
(nde326 ng/L), erythromycin (nde137 ng/L), propranolol
(nde40.1 ng/L), indomethacin (nde33.5 ng/L), ﬂuconazole (nd-
111 ng/L), levoﬂoxacin (nd-87.4 ng/L) and ifenprodil (nd-35.4 ng/L)
in surface water from the Mankyung River, South Korea. The same
research group documented the frequent detection of many phar-
maceuticals, hormones, and antibiotics in three major rivers, the
Han River, the Nakdong River and the Youngsan River in South
Korea [88]. Another study by Sim et al. investigated the occurrence
and distribution of pharmaceuticals in inﬂuents of WWTPs located
near major river basins in Korea. Results showed that non-steroidal
anti-inﬂammatory drugs, caffeine, and carbamazepine were
dominant in the inﬂuents and the distribution of pharmaceuticals
varied with sampling sites and periods [146].
Lin et al. quantiﬁed some pharmaceutical residues such as clo-
ﬁbric acid, ibuprofen, carbamazepine, naproxen, ketoprofen, and
diclofenac in tap water, groundwater, WWTPs and river water from
the Fu-Hsing River in China. None of the target compounds were
detected in tap water and groundwater. However, 30 ng/L of nap-
roxen was measured in the river water, while concentrations of
ibuprofen, carbamazepine and naproxen reached 30 ng/L, 420 ng/L,
and 170 ng/L respectively in WWTP efﬂuent [98]. Xu et al. exam-
ined several antibiotics in Victoria Harbour, Hong Kong and the
Pearl River in South China. Concentrations were below the limit of
quantiﬁcation in seawater but all of the target compounds except
amoxicillin were detected in the Pearl River at concentrationsranging from 11 to 67 ng/L and 66e460 ng/L, respectively [174].
Another study conducted in the urban riverine water of the
Pearl River Delta at Guangzhou, South China, revealed the presence
of the estrogenic hormone, estrone, at a maximum concentration of
65 ng/L, while acidic pharmaceuticals such as salicylic acid, cloﬁbric
acid and ibuprofen were detected in most of the water samples
with maximum concentrations of 2098, 248, and 1417 ng/L
respectively [131]. In a study of the uptake of antibiotics in irriga-
tion water by plants in Tianjin, China, most of the target analytes
including sulfamethoxazole, sulfadoxine, sulfachloropyridazine,
choramphenicol, tetracycline, lincomycin, chlortetracycline, oﬂox-
acin, and peﬂoxacin were detected in vegetables between 0.1 and
532 mg/kg [77]. Luo et al. reported the occurrence and transport of
tetracycline, sulfaonamide, quinolone and macrolide antibiotics in
the Haihe River Basin, China. The sources of the 12 antibiotics
studied were assessed as likely originating from veterinary appli-
cation in swine farms and ﬁsh ponds at concentrations ranging
from 0.12 to 47 mg/L [105]. A more recent study in Taihu Lake, China
detected eight pharmaceutically active compounds, namely: roxi-
thromycin, erythromycin, ibuprofen, diclofenac, propranolol, car-
bamazepine, E2, and EE2 in surface water and sediment samples
with maximum concentrations in the range of 8.74e118 ng/L and
0.78e42.5 ng/L dry weight respectively [173]. Ma et al. also
examined some pharmaceutically active drugs in Dongting Lake,
China. The most frequently detected compound was caffeine fol-
lowed by diclofenac, DEET, mefenamic acid, ﬂuoxetine, ibuprofen,
and carbamazepine with mean concentrations between 2.0 and
80.8 ng/L [106].
In Northern Taiwan [48], reported 4 pharmaceutical residues in
wastewater STP and in seawater around the efﬂuent discharge area.
The pharmaceutical concentrations measured in inﬂuent were:
cloﬁbric acid (104e109 ng/L), diclofenac (152e185 ng/L), ibuprofen
(724e2200 ng/L), and ketoprofen (128e184 ng/L). Corresponding
concentrations in efﬂuent were: 95e102 ng/L, 100e131 ng/L,
552e1600 ng/L, and 68e128 ng/L respectively.
1.7.2. Sediment and sewage sludge
Lei et al. studied concentrations of six estrogens including:
diethylstilbestrol (DES), estrone (E1), b-estradiol (E2), estriol (E3),
17a-ethynylestradiol (EE2), and b-estradiol 17-valerate (EV) in
surface water and sediment sampled from three rivers in Tianjin
area, northern China. The concentrations of all six estrogens ranged
from 0.98 to 51.6 ng/g in sediment and varied for each river [96].
Yang et al. measured four classes of antibiotics, namely: sulpho-
namides, macrolides, ﬂuoroquinolones and tetracyclines in sedi-
ment of the Pearl River in China. Oﬂoxacin was detected at the
highest concentration of 1560 mg/kg [176]. In another study con-
ducted by Liu and co-workers, high concentrations of chloram-
phenicol (5.8e47.4 mg/L), oxytetracycline (0.2e5.7 mg/L), and
tetracycline (0.7e65.2 mg/L) were observed in the sediment of the
Nanming River, Guiyang city, China during summer [99].
Ramaswany et al. studied antiepileptic, antimicrobial and pre-
servative compounds in surface water and sediment from the
Kaveri, Tamiraparani, and Vellar rivers in India. The maximum
concentrations reported for the antimicrobial triclosan in sediment
in the three rivers were 85.3, 46.9 and 32.1 ng/g respectively [133].
A study by Zhou et al. reported the occurrence of 4 classes of
commonly used antibiotics including sulphonamides, ﬂuo-
roquinolones, tetracycline, and macrolides in the sediments of the
Yellow River, Hai River and Liao River in Northern China. Higher
concentrations were detected for most antibiotics in the Hai River
sediment compared to the other rivers. The most frequently
detected antibiotics were norﬂoxacin, oﬂoxacin, ciproﬂoxacin and
oxytetracycline at concentrations up to 5770,1290, 653 and 652 ng/
g respectively [186]. Another study examined the occurrence of
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Baiyangdian Lake in North China. While sulphonamides were the
dominant antibiotics in lake water, quinolones were prominent in
sediments at concentrations of 0.86e1563 ng/L and 65.5e1166 mg/
kg respectively [97].
1.7.3. Biota
The catastrophic decline in the vulture population in Pakistan
has been partially attributed to dietary exposure of vultures to
diclofenac-treated livestock. Speciﬁcally, the diclofenac concen-
trations of 0.051e0.643 mg/g were found in the kidneys of all 25
vultures that died of renal failure [121]. Li et al. also detected 13
antibiotics in most of the studied hydrophyte samples (aquatic
plants) such as: Salvinia natans (Sal), Hydrocharis dubia (Hyd) and
Ceratophyllum demersum (Cer) and four crustacean species
including: crab (Eriocheir sinensis), river snail (Viva parus), shrimps
(Macrobrachium nipponense) and lobster (Palinuridae), 7 ﬁsh spe-
cies: topmouth gudgeon (Pseudorasbora parva), loach (Misgurnus
anguillicaudatus), yellow catﬁsh (Pelteobagrus ﬂuvidraco), to
mention but a few from Baiyangdian Lake, China. The concentra-
tions of antibiotics in Sal, Cer and Hyd were 1769 mg/kg, 253 mg/kg
and 129 mg/kg respectively [97]. Other studies have also reported
concentrations of ciproﬂoxacin in the aquatic plant (Echinodorus
amazonicus) as high as 795 mg/kg [28,180].
Liu et al. also reported steroid estrogens at concentrations up to
11.3 ng/g dry weight in wild ﬁsh species such as crucian carp, carp,
and silvery minnow from Dianchi Lake in Southern China. Liver
displayed highest estrogen accumulation, followed by gills and
muscle [100]. Following a study of ﬂuoroquinolones in the aqua-
culture environment of the Pearl River Delta, South China, He et al.
reported the accumulation of ﬂuoroquinolones in Siganus fusces-
cens from Hailing island, Sparus microcephalus from Dapeng'ao and
Lutianus argentimaculatus from Hailing island, at concentrations of
255, 133 and 5 ng/g wet weight respectively, with concentrations
higher in liver than inmuscle tissue. ~Concentrations of norﬂoxacin
were higher than those of ciproﬂoxacin and enroﬂoxacinin in both
tissues [69].
1.8. Australia
1.8.1. Wastewater and surface water
Data exists demonstrating the presence of numerous pharma-
ceuticals in efﬂuents, river systems, marine sediments and sewage
sludge in Australia as well as New Zealand. During a national survey
of trace organic contaminants in Australian rivers, the most
commonly detected contaminants were pharmaceuticals such as:
salicylic acid, paracetamol, carbamazepine, and caffeine at
maximum concentrations of 1530 ng/L, 7150 ng/L, 682 ng/L and
3770 ng/L respectively [144]. A study by Ref. [162] reported the
occurrence of antibiotics in three hospital efﬂuents, ﬁve WWTPs,
six rivers and a drinking water catchment within watersheds of
South-East Queensland, Australia. The results of the study showed
high concentrations of antibiotics in the hospital efﬂuent (up to
14.5 mg/L). Concentrations of target antibiotics in the studied
WWTP inﬂuent and efﬂuent were up to 64 mg/L and 3.4 mg/L
respectively, while river water samples contained up to 2 mg/L of
target analytes. Interestingly, none of the studied antibiotics were
detected in drinking water.
[179] detected the antimicrobial triclosan in wastewaters and
biosolids from Australia WWTPs. Concentrations of triclosan
ranged from 23 to 434 ng/L and 0.09e16.79 mg/kg for the WWTP
efﬂuents and biosolids respectively. Triclosan at concentrations up
to 75 ng/L was detected in surface waters (outfall, upstream, and
downstream) from ﬁve rivers receiving efﬂuent discharge from the
investigated WWTPs. Costanzo et al. reported detection of sixantibiotics entering local waterways of South East Queensland.
Among the antibiotics investigated, cephalexin had the highest
concentration of 2000 ng/L being the second most prescribed
antibiotic in Australia [39].
1.9. Sediment and sewage sludge
Few studies have been conducted in Australia in terms of
monitoring pharmaceuticals in sediments [168]. investigated iso-
topic exchangeability to measure the available fraction of carba-
mazepine in river sediment collected from Mackreath Creek and
Scott Creek in South Australia. The study demonstrated isotopic
exchangeability as a relatively quick and simple alternative to batch
desorption techniques for the assessment of the available fraction
of the carbamazepine in sediments following their release into
aquatic ecosystems [168]. Another study reported the detection of
emerging contaminants including pharmaceuticals in the
estuarine-receiving environment around Auckland, New Zealand.
21 out of 46 targeted pharmaceuticals were quantiﬁed in one or
more estuarine sediments with concentrations ranging from 0.2 to
7.7 ng/g. The highest concentrations were detected for acetamin-
ophen (7.7 ng/g) and naproxen (5.5 ng/g) [148].
1.10. Africa
1.10.1. Wastewater and surface water
Currently, very little is known about the occurrence, fate and
behaviour of PPCPs in the African freshwater aquatic environment.
In most developing countries in Africa, where the waste disposal
system is basically through landﬁll, it is important to monitor the
presence of PPCPs, since some of these PPCPs are not easily
degradable either through biodegradation or photodegradation.
Moreover, they can contaminate groundwater which constitutes a
major water supply for a large proportion of the population in arid
regions of Africa.
Antimalarial drugs such as artemether and lumefantrine, that
are widely used in Africa for the treatment of the malaria parasite,
as well as amoxicillinwere detected at concentrations ranging from
3 to 32 mg/L in Tanzania [115]. A study in South Africa reported the
presence of pharmaceuticals such as erythromycin, chloramphen-
icol, nalidixic acid, tetracycline, sulfamethoxazole, acetaminophen,
atenolol, diclofenac, ibuprofen, caffeine and others in Umgeni sur-
face water and in a dam along the Umgeni River used for water
supply in KwaZulu-Natal South Africa. There was 100% occurrence
of the analytes studied in wastewater, with caffeine displaying the
highest average concentration at 61 ± 5 mg/L and nalidixic acid
being the most abundant antibiotic at 31 ± 3 mg/L. The waste
treatment process reduced the inﬂuent concentrations by 43e94%
before discharge except for atenolol removal (for which reduction
was only 15%). Analyte concentrations were generally much lower
in the surface water (<10 mg/L), except acetaminophen (16 mg/L)
and atenolol (39 mg/L) [1]. A more recent study reported residues of
pharmaceuticals in wastewater from Msunduzi River, KwaZulu-
Natal, South Africa. Results revealed ibuprofen to display the
highest concentrations at 117 mg/L and 85 mg/L in wastewater and
surface water respectively. Concentrations of antibiotics in surface
water were generally lower (>10 mg/L) but up to 34.5 mg/L in
wastewater [109]. In Kenya [84], investigated 10 classes of phar-
maceutically active ingredients (PAIs) in Nairobi River. Analgesics,
anti-inﬂammatory and antiepileptic agents were the most preva-
lent PAIs at about 30e35 mg/L, followed by antibiotics/antimalarial
drugs at up to 25e30 mg/L, while antivirals were detected at up to
10e15 mg/L. Another study reported the occurrence of antibiotics
and antivirals in the Nairobi River Basin, Kenya. The maximum
concentrations in river water for sulfamethoxazole, trimethoprim,
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2.6, 0.5, 5.4, 4.8, and 7.7 mg/L respectively [118].
Olaitan et al. reported the detection of pharmaceutical com-
pounds in surface and groundwater samples collected from an
irrigation canal and several wells in a pharmaceutical industrial
area of Sango Ota, Ogun State, Nigeria. The average concentrations
of the targeted pharmaceuticals such as diclofenac, chloroquine,
paracetamol and ciproﬂoxacinwere 17 mg/L, 5 mg/L, 3 mg/L and 1 mg/
L, respectively [122]. To augment the limited database on the
occurrence of pharmaceutical compounds in the Nigerian envi-
ronment, a monitoring campaign was conducted in Lagos. Phar-
maceutical residues in wastewater impacted surface waters and
sewage sludge were quantiﬁed using LC-MS/MS. For the surface
water, ibuprofen showed the highest concentrations up to 8.8 mg/L,
while diclofenac was more abundant in sewage sludge with con-
centrations up to 1100 mg/kg dry weight [123].
1.10.2. Sediment and sewage sludge
Aspirin, diclofenac, ketoprofen and ibuprofen were measured in
sediment samples collected from Msunduzi River, kwazulu-Natal,
South Africa. The highest concentrations in sediment were
observed for aspirin (212e427 ng/g). The concentrations of diclo-
fenac, ketoprofen, and ibuprofen detected in sediment were be-
tween 57 and 309, 7e57 and 5e11 ng/g respectively [2]. Matongo
et al. also detected ibuprofen in sediment from the Msunduzi River,
KwaZulu-Natal, South Africa at concentrations as high as 659 ng/g
[109].
2. Summary, research gaps and future perspectives
PPCPs are a group of emerging contaminants with physico-
chemical characteristics that distinguish them from other con-
taminants (e.g. persistent organic pollutants). Pharmaceuticals are
structurally designed to maximise their biological activity at low
concentrations and developed to produce a prolonged action. These
properties highlight the risks associated with the inadvertent
presence of PPCPs in the environment. This review highlights that
aquatic organisms are continuously exposed to PPCPs throughout
their life cycle and there is mounting evidence that the unintended
presence of these contaminants in the aquatic environment may
exert detrimental impacts on aquatic life. To date, little is known
about the impacts of their environmental presence on humans. The
major point source of PPCPs into the aquatic environment is
WWTPs, alongside other sources such as agricultural runoff, PPCP
manufacturing sites, and aquaculture. Evidence suggests that
WWTPs are not completely capable of removing PPCPs during
treatment processes. Therefore, treated efﬂuents discharged into
receiving water bodies may still contain substantial PPCP residues
and there is a clear need for the development of advanced WWTP
technologies to more efﬁciently remove/degrade PPCPs.
Despite the recent advances in analytical techniques that allow
sensitive multi-residue analysis of several PPCPs in different envi-
ronmental matrices, and clearly demonstrate the unintended
environmental presence of such chemicals, this literature review
reveals gaps in the current state-of-knowledge about this emerging
class of environmental contaminants.
It is apparent from this review that more studies of PPCPs are
required to characterise their environmental presence in devel-
oping countries, as there are currently far fewer data for Africa, Asia
and South America compared to the Europe and North America.
Moreover, while sorption to sediment particles was suggested to
play a role in determining the fate of PPCPs in the freshwater
aquatic environment, there are no detailed studies addressing the
behaviour and dynamics of PPCPs in freshwater systems, or how
sediment may act as a sink for these contaminants or source ofPPCPs for bottom-feeding aquatic biota.
Currently, very little is known about the levels of PPCPs in biota
in general. Few studies have investigated PPCP residues in ﬁsh,
birds and mammals. There is also a lack of information on the po-
tential trophic magniﬁcation of these compounds or the inﬂuence
of prenatal exposure on the possible transfer of PPCPs to birds' eggs
and other nascent wildlife.
It is also imperative to further the current understanding of the
toxicological implications of chronic exposure to complex mixtures
of PPCPs at sub-therapeutic levels in both target and non-target
organisms. More research is also needed to characterise the inﬂu-
ence of such exposure on the status of public health in contami-
nated areas (e.g. impacts on malarial resistance in Africa or fertility/
fecundability in areas contaminated with estrogenic hormones).
Although data exist about the presence of PPCPs in the fresh-
water aquatic environment, there appear gaps in knowledge about
the seasonal variability in concentrations of commonly and
consistently detected PPCPs in the aquatic environment [184].
highlighted seasonal variations in concentrations of some phar-
maceuticals in water samples collected between December 2009
and 2010 from the river Medway, Kent, UK, with the highest con-
centrations detected in June. Further investigation is needed to
provide more detailed deﬁnition of seasonal variations of PPCPs in
various environmental compartments. Another important area that
has to be properly addressed is the bioaccumulation of PPCPs in
aquatic organisms such as: algae, crustaceans, and ﬁsh. Initial in-
vestigations of this issue [37,163,166] highlight its importance and
further study of the potential bioaccumulation by aquatic biota is
warranted, including its implications for human exposure via
consumption of contaminated ﬁsh/shellﬁsh.
Finally, future research on PPCPs should not focus only on the
parent (intact) compounds but also on their potential degradation
products/metabolites in various matrices. This is of importance
because such degradation products/metabolites formed under
various environmental conditions (temperature, pressure, UV light
… etc) or by non-target organisms may differ from those formed
under human physiological conditions. Consequently, this may
produce more toxic/bioaccumulative compounds than the parent
PPCPs.
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